Vitrolife
215.2
SEK
-1.74 %
VITR
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Less than 1K followers
-1.74%
-1.01%
+0.09%
-9.2%
-3.76%
+22.48%
-44.16%
+5.7%
+3,406.6%
Vitrolife is a global provider of solutions in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics in enhancing their practice as well as the outcome of a patient’s fertility treatment. Vitrolife´s products and services are available globally, and the company is headquartered in Gothenburg, Sweden.
Read moreMarket cap
29.15B SEK
Turnover
19.32M SEK
Revenue
3.61B
EBIT %
21.7 %
P/E
56.78
Dividend yield-%
0.51 %
Financial calendar
16.4
2025
Interim report Q1'25
29.4
2025
General meeting '25
30.4
2025
Annual dividend
ShowingAll content types
Vitrolife AB (publ): Fourth quarter and full year report, 2024: A strong finish to the year
Vitrolife AB (publ): Conference call full year report 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools